Aduro biotech, inc. (ADRO)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Revenue:
Total revenue

27,270

17,258

16,383

14,647

12,398

15,087

16,123

18,977

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration and license revenue

-

-

-

-

-

-

-

-

-

-

-

-

50,382

-

80,823

95,749

66,434

71,689

40,005

22,168

0

-

0

0

-

Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

356

782

1,001

1,290

1,184

820

662

351

0

0

0

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

50,423

-

81,179

96,531

67,435

72,979

48,496

31,836

22,938

13,389

0

0

0

Operating expenses:
Research and development

65,379

67,045

67,493

70,658

73,202

75,836

81,139

86,918

88,938

89,382

87,329

81,921

87,363

87,718

89,512

82,279

68,930

58,649

43,515

37,560

29,430

23,513

0

0

0

General and administrative

34,390

34,795

33,901

34,367

35,214

36,035

35,791

35,100

34,518

33,751

33,003

33,101

33,556

34,277

35,060

33,412

30,594

27,805

22,496

17,568

13,820

8,994

0

0

0

Restructuring and related expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on impairment of intangible assets

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of intangible assets

554

554

518

524

532

584

589

590

579

559

547

540

544

549

504

366

226

89

0

0

0

-

-

-

-

Total operating expenses

106,639

107,400

113,944

112,575

115,974

116,447

117,519

122,608

124,035

123,692

120,879

115,562

121,463

122,544

125,076

116,057

99,750

86,543

66,011

55,128

43,250

32,507

0

0

0

Loss from operations

-79,369

-90,142

-97,561

-97,928

-103,576

-101,360

-101,434

-105,792

-103,941

-106,453

-103,518

-98,201

-71,040

-71,863

-43,897

-19,526

-32,315

-13,564

-17,515

-23,292

-20,312

-19,118

0

0

0

Loss from remeasurement of fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26,077

26,234

26,209

0

-

0

0

-

Interest income

4,900

5,451

5,726

5,713

5,556

5,284

4,908

4,553

3,993

3,444

2,994

0

0

-

0

-

-

-

-

-

-

-

-

-

-

Interest income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-

-

0

-

-

Gain on extinguishment of convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Other expense, net

-93

-93

-103

-50

-67

-64

-36

-186

-230

-218

-205

-77

-22

-40

-211

-207

-191

-161

673

1,525

1,862

1,512

0

0

0

Total other income

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income tax

-74,562

-84,784

-91,938

-92,265

-98,087

-96,140

-96,562

-101,425

-100,178

-103,227

-100,616

-95,603

-68,647

-69,684

-42,213

-18,265

-48,293

-39,308

0

0

0

-

-

-

-

Income tax benefit

-8,077

-2,412

-2,661

-794

-797

-783

-1,394

-4,883

-8,633

-11,364

-5,318

10,226

15,486

21,464

16,269

4,599

3,127

-99

0

0

0

-

-

-

-

Net loss

-66,520

-82,372

-89,277

-91,471

-97,290

-95,357

-95,168

-96,542

-91,545

-91,863

-95,298

-105,829

-84,133

-91,148

-58,482

-22,864

-51,420

-39,209

-43,229

-48,480

-25,846

-17,014

0

0

0

Net loss per common share, basic and diluted

-0.09

-0.25

-0.26

-0.23

-0.29

-0.33

-0.29

-0.31

-0.28

-0.34

-0.33

-0.27

-0.32

-

-0.54

-

-0.45

-

-

-

-39.97

-

-

-12.27

-26.34

Shares used in computing net loss per common share, basic and diluted

80,757

80,504

80,232

80,032

79,673

79,438

79,086

78,817

77,906

77,093

75,167

71,101

68,242

-

65,134

-

63,802

-

-

-

415

-

-

295

295

Net (loss) income per common share, basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.04

-

-

0.01

-0.50

-

-

-14.24

-

-

Net (loss) income per common share, diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.03

-

-

0.01

-0.50

-

-

-14.24

-

-

Shares used in computing net loss per common share, basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64,434

-

-

62,274

52,653

-

-

328

-

-

Shares used in computing net loss per common share, diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

71,473

-

-

71,726

52,653

-

-

328

-

-

Collaboration and license revenue
Total revenue

27,270

17,258

16,383

14,647

12,398

15,087

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-